Altshuler Shaham LTD Amgen Inc Transaction History

Altshuler Shaham LTD

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $17,387 - $19,615	68 New	68 $19,000
Q2 2023 Jul 24, 2023	SELL	$214.27 - $253.37 $3,642 - $4,307	-17 Reduced 9.34%	165 $36,000
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $124,410 - $151,635	-551 Reduced 75.17%	182 $43,000
Q4 2022 May 09, 2023	SELL	$229.03 - $291.01 $67,563 - $85,847	-295 Reduced 28.7%	733 $192,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $7,182 - $8,100	-32 Reduced 3.02%	1,028 $235,000
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $159,420 - $177,407	691 Added 187.26%	1,060 $258,000
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $80,910 - $89,508	369 New	369 $89,000
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $22,287 - $26,540	-103 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $3,519 - $3,914	-15 Reduced 12.71%	103 $26,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $2,373 - $2,912	12 Added 11.32%	118 $28,000
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $12,027 - $15,952	-66 Reduced 38.37%	106 $22,000
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $23,840 - $30,643	126 Added 273.91%	172 $42,000
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $8,009 - $9,596	46 New	46 $9,000
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $7,415 - $8,359	-41 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $7,314 - $8,538	41 New	41 $8,000
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $32,055 - $36,137	-173 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $28,726 - $32,266	173 New	173 $9,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.